ticagrelor and eicosapentaenoic-acid-ethyl-ester

ticagrelor has been researched along with eicosapentaenoic-acid-ethyl-ester* in 1 studies

1 other study(ies) available for ticagrelor and eicosapentaenoic-acid-ethyl-ester

Article	Year
Novel antibody-based reversal agent for ticagrelor. Nature reviews. Cardiology, 2019, Volume: 16, Issue:6 Topics: Cardiovascular Diseases; Eicosapentaenoic Acid; Humans; Hypertriglyceridemia; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk Factors; Ticagrelor	2019